CCND1 and Familial prostate cancer: In the present study, ten case-control studies on the CCND1 A870G polymorphism and prostate cancer risk, which were previously published, were analyzed via a meta-analysis to examine a more specific association between the CCND1 A870G polymorphism and prostate cancer risk and various published observational studies.